Wordt geladen...
Lessons learned from Ebola Vaccine R&D during a public health emergency
In spite of a complete lack of Research and Development (R&D) preparedness, the 2013–2016 West-Africa Ebola experience demonstrated that it is possible to compress R&D timelines to less than a single year, from a more usual decade or longer. This is mostly to be credited to an unprecedented...
Bewaard in:
| Gepubliceerd in: | Hum Vaccin Immunother |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6183317/ https://ncbi.nlm.nih.gov/pubmed/29452047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1442161 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|